LAKE FOREST, Calif.-- Apria Healthcare Group is no longer for sale.

Instead of looking for a buyer, the giant provider--which has 500 branches in 50 states--will "focus 100 percent on revenue growth and operating improvements," company officials announced Tuesday. The company also said it will repurchase up to $250 million of its outstanding common stock.

While there were extensive discussions with possible investors after its June decision to sell, according to the announcement, the company's board of directors ultimately decided none of the proposals represented Apria's "intrinsic value and prospects for future appreciation."

Apria's third-quarter revenues increased just 1 percent over revenues for the third quarter of 2004, according to quarterly financial results released with the announcement. Revenues were $367.6 million for the quarter ended Sept. 30 versus $364.6 million for the same period last year. Net income of $19.3 million for the quarter compared to $29.8 million for the same period in 2004.

Reimbursement cuts that went into effect this year for HME, oxygen and respiratory medications negatively affected the 2005 figures, Apria said. Earlier this month, the company dropped its revenue expectations estimate for 2005 to 2 to 3 percent, but currently estimates revenue growth for 2006 at 5 percent.

Apria said several contract wins and expansions will help accelerate its organic growth. The company recently signed a new three-year contract with Cigna HealthCare, effective February 2006, and renewed an existing five-year contract with Kaiser Permanente. In addition, a national contract with Aetna has been expanded.

"With these new contracts in hand and our recent success in gaining Medicare oxygen business, we believe we have the basis for solid organic growth in 2006," company CEO Lawrence Higby said in a statement. "We also expect to benefit from expanded Medicare Advantage business as new beneficiaries become eligible for Medicare."

During the third quarter, Apria acquired five small businesses totaling $4.1 million. For the year, the company completed 19 acquisitions for $99.5 million.

"The company has a strong future ahead of it," Higby said. "Throughout the summer, we have remained focused on implementing various initiatives related to logistics, revenue management, centralized Medicare billing and centralized pharmacy management--all of which have made good progress. Given our third quarter revenues, we will redouble our focus on revenue growth while continuing to pursue the operating initiatives which should further enhance long-term shareholder value."